Ubrelvy
Active Ingredient(s): UbrogepantFDA Approved: * December 23, 2019
Pharm Company: * ALLERGAN
Category: Migraine / Tension Headache
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Ubrelvy Overview
Ubrogepant, sold under the trade name Ubrelvy, is a medication used for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults.[1] It is not indicated for the preventive treatment of migraine.[1] It is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved for the acute treatment of migraine.[1] The most common side effects are nausea, tir...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ubrogepant
Recent Ubrelvy Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Ubrogepant
- Tablet: 100mg, 10mg, 50mg
NDC Database Records for Ubrelvy: (2 results)
Sorted by National Drug Code- 0023-6498 Ubrelvy 50 mg Oral Tablet by Allergan, Inc.
- 0023-6501 Ubrelvy 100 mg Oral Tablet by Allergan, Inc.